Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
Tipo de documento
Intervalo de ano de publicação
1.
Diabetes Spectr ; 32(3): 221-225, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31462877

RESUMO

IN BRIEF Diabetes care lends itself to interactions centered around data-counting carbohydrate for meals, calculating correction doses, viewing logbooks or device data, and discussing A1C levels-and digital technology has enhanced diabetes care through the improved collection and analysis of data from multiple sources. With these technological advancements have come great improvements in quality of life for people with type 1 diabetes. These technologies allow for more informed and immediate decision-making through better access to blood glucose data and sometimes allow the devices themselves to make decisions, removing the need for patients or clinicians to be involved in decision-making altogether. At the same time, these new technologies bring new challenges for both patients and health care providers, who must now analyze and make sense of more diabetes data.

2.
J Diabetes Sci Technol ; 11(4): 800-807, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28617628

RESUMO

BACKGROUND: A novel software application, Blip, was created to combine and display diabetes data from multiple devices in a uniform, user-friendly manner. The objective of this study was to test the usability of this application by adults and caregivers of children with type 1 diabetes (T1D). METHODS: Patients (n = 35) and caregivers of children with T1D (n = 30) using an insulin pump for >1 year ± CGM were given access to the software for 3 months. Diabetes management practices and the use of diabetes data were assessed at baseline and at study end, and feedback was gathered in a concluding questionnaire. RESULTS: At baseline, 97% of participants agreed it was important for patients to know how to interpret glucose data. Most felt that clinicians and patients should share the tasks of reviewing data, finding patterns, and making changes to their insulin plans. However, despite valuing shared responsibility, at baseline, 43% of participants never downloaded pump data, and only 9% did so at least once per month. At study end, 72% downloaded data at least once during the 3-month study, and 38% downloaded at least once per month. Regarding the software application, participants liked the central repository of data and the user interface. Suggestions included providing tools for understanding and interpreting glucose patterns, an easier uploading process, and access with mobile devices. CONCLUSIONS: Collaboration between developers and researchers prompted iterative, rapid development of data visualization software and improvements in the uploading process and user interface, which facilitates clinical integration and future clinical studies.


Assuntos
Automonitorização da Glicemia/métodos , Diabetes Mellitus Tipo 1/sangue , Software , Adolescente , Adulto , Glicemia/análise , Cuidadores , Criança , Pré-Escolar , Diabetes Mellitus Tipo 1/tratamento farmacológico , Feminino , Humanos , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Sistemas de Infusão de Insulina , Masculino , Projetos Piloto , Adulto Jovem
3.
J Am Med Inform Assoc ; 23(2): 324-32, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26338218

RESUMO

OBJECTIVE: Develop a device-agnostic cloud platform to host diabetes device data and catalyze an ecosystem of software innovation for type 1 diabetes (T1D) management. MATERIALS AND METHODS: An interdisciplinary team decided to establish a nonprofit company, Tidepool, and build open-source software. RESULTS: Through a user-centered design process, the authors created a software platform, the Tidepool Platform, to upload and host T1D device data in an integrated, device-agnostic fashion, as well as an application ("app"), Blip, to visualize the data. Tidepool's software utilizes the principles of modular components, modern web design including REST APIs and JavaScript, cloud computing, agile development methodology, and robust privacy and security. DISCUSSION: By consolidating the currently scattered and siloed T1D device data ecosystem into one open platform, Tidepool can improve access to the data and enable new possibilities and efficiencies in T1D clinical care and research. The Tidepool Platform decouples diabetes apps from diabetes devices, allowing software developers to build innovative apps without requiring them to design a unique back-end (e.g., database and security) or unique ways of ingesting device data. It allows people with T1D to choose to use any preferred app regardless of which device(s) they use. CONCLUSION: The authors believe that the Tidepool Platform can solve two current problems in the T1D device landscape: 1) limited access to T1D device data and 2) poor interoperability of data from different devices. If proven effective, Tidepool's open source, cloud model for health data interoperability is applicable to other healthcare use cases.


Assuntos
Diabetes Mellitus Tipo 1/terapia , Software , Humanos , Propriedade , Integração de Sistemas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA